SHEETS SMITH WEALTH MANAGEMENT

Position in AVXL — Anavex Life Sciences Corp.

CIK 1157436 WINSTON-SALEM, NC

Position in AVXL

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$184,560

-$177,101 QoQ

Shares Held

71,259

-39.5% QoQ

Ownership

0.077%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

of 13 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SHEETS SMITH WEALTH MANAGEMENT holds $5,482,729 across 3 Biotechnology names. AVXL ranks #3 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IBRX	ImmunityBio, Inc.	512,572	$4,487,567
2	REGN	Regeneron Pharmaceuticals, Inc.	1,300	$810,602
3	AVXL	Anavex Life Sciences Corp. This page	71,259	$184,560

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$184,560	71,259	-39.5%	Shares	Sole	2026-07-13
2026-03-31	$361,661	117,805	+0.1%	Shares	Sole	2026-04-16
2025-12-31	$418,997	117,696	—	Shares	Sole	2026-01-20
No filing history on record for this holder in this stock.